Transce3nd’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14
Closed -$328 614
2025
Q2
$328 Hold
14
﹤0.01% 1137
2025
Q1
$321 Sell
14
-8,304
-100% -$196K ﹤0.01% 1090
2024
Q4
$195K Buy
+8,318
New +$197K 0.07% 171

Other funds holding IBD

Transce3nd's IBD Position: Q3 2025 in Review

Transce3nd sold out of Inspire Corporate Bond ETF (IBD) in Q3 2025, closing a stake of 14 shares — an estimated $328 sold.

Transce3nd first reported a position in IBD in Q4 2024 and held it in 3 quarters. The position peaked at $195K in Q4 2024. 97 funds tracked by Wall St. Rank hold IBD as of Q3 2025.

  • Transce3nd reported no remaining Inspire Corporate Bond ETF position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 14 Inspire Corporate Bond ETF shares in Q3 2025, an estimated $328.
  • Transce3nd first reported a position in Inspire Corporate Bond ETF in Q4 2024 and held it in 3 quarters.
  • Transce3nd's Inspire Corporate Bond ETF position peaked at $195K in Q4 2024.
  • 97 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.